What is Allergy Plus?
Allergy Plus, LLC. is a healthcare solutions provider focused on enhancing patient care and practice revenue. The company partners with medical practices to integrate advanced allergy testing and procedures directly within primary care settings. These offerings are designed to be seamlessly incorporated into routine patient visits, minimizing inconvenience while expanding the scope of services available. By introducing state-of-the-art diagnostic capabilities, Allergy Plus aims to empower healthcare providers to increase revenue streams and offer more comprehensive care.
How much funding has Allergy Plus raised?
Allergy Plus has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Allergy Plus
PPP
Public-Private Partnership
What's next for Allergy Plus?
The substantial capital infusion, particularly the recent strategic investment, positions Allergy Plus for accelerated expansion and innovation. As a company in a large-scale, late-stage funding phase, Allergy Plus is likely to focus on scaling its operations, enhancing its technological infrastructure, and potentially broadening its service offerings. This strategic backing suggests a clear path toward solidifying its market leadership and further developing its unique value proposition within the healthcare diagnostics and services industry. Future developments may include strategic partnerships and market penetration initiatives.
See full Allergy Plus company page
